Allianz Asset Management »

Arcus Biosciences Incorporated shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.0M 67k 15.23
2023-12-31 $445k 23k 19.10
2023-09-30 $664k 37k 17.95
2023-06-30 $756k 37k 20.31
2023-03-31 $1.3M 71k 18.24
2020-12-31 $205k 7.9k 25.95
2020-09-30 $908k 53k 17.13
2020-06-30 $2.5M 101k 24.74
2020-03-31 $1.4M 101k 13.88

More positions owned by Allianz Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)
Vici Pptys (VICI)
Applied Materials (AMAT)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Eli Lilly & Co. (LLY)

View all positions for Allianz Asset Management

Top funds holding Arcus Biosciences Incorporated

BlackRock
BlackRock
Vanguard Group
Woodline Partners
State Street Corporation
Point72 Asset Management
Siren
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Geode Capital Management
Suvretta Capital Management
Bnp Paribas Investment Partners
Decheng Capital

View all funds holding Arcus Biosciences Incorporated